articleJournal of Pharmacology and Experimental TherapeuticsJul 1, 2002Closed access

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

KDKevin D. BurrisTFThaddeus F. MolskiCXCen XuERElaine RyanKTKatsura Tottori

Bristol-Myers Squibb (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

920
total citations
FWCI
12.88
Percentile
100%
References
49
Citations per year

Authors

8

Topics & keywords

Topics
Keywords
  • Aripiprazole
  • Partial agonist
  • Dopamine receptor D2
  • Agonist
  • Chemistry
  • Pharmacology
  • Dopamine
  • Endogenous agonist
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.